Comparison of Performance between ARC-HBR Criteria and PRECISE-DAPT Score in Patients Undergoing Percutaneous

Sun Young Choi1,2, Moo-Hyun Kim1, Kwang-Min Lee1

  • 1Department of Cardiology, Dong-A University Hospital, Busan 49201, Korea.

Insights

Predicting bleeding risk after percutaneous coronary intervention (PCI) is crucial. Both Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria and the PRECISE-DAPT score effectively predict bleeding events and death in Korean patients on dual antiplatelet therapy (DAPT).

Area of Science:

  • Cardiology
  • Clinical Research
  • Medical Informatics

Background:

  • Managing bleeding risk is critical for patients undergoing percutaneous coronary intervention (PCI).
  • Standardized tools are needed to predict bleeding risk in this population.
  • The Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria and PRECISE-DAPT score are proposed risk assessment tools.

Purpose of the Study:

  • To compare the predictive performance of ARC-HBR criteria and the PRECISE-DAPT score for bleeding events in Korean patients undergoing PCI.
  • To evaluate the ability of these scores to predict all-cause death in the same cohort.
  • To assess the utility of these scores in patients receiving dual antiplatelet therapy (DAPT).

Main Methods:

  • A retrospective analysis of 1418 consecutive patients undergoing PCI between January 2012 and December 2018.
  • Calculation and comparison of the predictive accuracy (Area Under the Curve - AUC) of ARC-HBR criteria and PRECISE-DAPT score for various bleeding definitions (BARC, TIMI, GUSTO) and all-cause death.
  • Statistical comparison of the discriminant ability between the two scoring systems.

Main Results:

  • Both ARC-HBR criteria and PRECISE-DAPT score demonstrated high predictive performance for bleeding events across different definitions (AUCs ranging from 0.68 to 0.82).
  • Both scores also showed high predictive accuracy for all-cause death (AUC 0.82).
  • The predictive ability of the PRECISE-DAPT score was not significantly different from the ARC-HBR criteria for both bleeding events and all-cause death.

Conclusions:

  • The ARC-HBR criteria and PRECISE-DAPT score are effective tools for predicting 1-year bleeding events in Korean patients treated with DAPT after PCI.
  • The simpler PRECISE-DAPT score offers comparable utility to the ARC-HBR criteria in predicting bleeding and all-cause death post-PCI.
  • These findings support the use of either score for risk stratification in this patient population.